186 related articles for article (PubMed ID: 17613287)
1. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.
Papale M; Pedicillo MC; Thatcher BJ; Di Paolo S; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):205-13. PubMed ID: 17613287
[TBL] [Abstract][Full Text] [Related]
2. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
3. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
4. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis.
Papale M; Pedicillo MC; Di Paolo S; Thatcher BJ; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
Clin Chem Lab Med; 2008; 46(1):89-99. PubMed ID: 18020972
[TBL] [Abstract][Full Text] [Related]
5. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads.
Deng B; Dong Z; Liu Y; Wang C; Liu J; Wang C; Qu X
Clin Chim Acta; 2010 Aug; 411(15-16):1051-7. PubMed ID: 20361951
[TBL] [Abstract][Full Text] [Related]
6. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
[TBL] [Abstract][Full Text] [Related]
7. Salivary protein/peptide profiling with SELDI-TOF-MS.
Schipper R; Loof A; de Groot J; Harthoorn L; van Heerde W; Dransfield E
Ann N Y Acad Sci; 2007 Mar; 1098():498-503. PubMed ID: 17435159
[TBL] [Abstract][Full Text] [Related]
8. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
9. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
[TBL] [Abstract][Full Text] [Related]
10. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
11. Sample handling for mass spectrometric proteomic investigations of human urine.
Petri AL; Høgdall C; Christensen IJ; Simonsen AH; T'jampens D; Hellmann ML; Kjaer SK; Fung ET; Høgdall E
Proteomics Clin Appl; 2008 Sep; 2(9):1184-93. PubMed ID: 21136916
[TBL] [Abstract][Full Text] [Related]
12. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
13. Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
Xue A; Gandy RC; Chung L; Baxter RC; Smith RC
Pancreatology; 2012; 12(2):124-9. PubMed ID: 22487522
[TBL] [Abstract][Full Text] [Related]
14. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
15. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
Harezlak J; Wang M; Christiani D; Lin X
Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
17. Time course proteomic profile of rat acute myocardial infarction by SELDI-TOF MS analysis.
Zhang G; Zhou B; Zheng Y; Feng K; Rao L; Zhang J; Xin J; Zhang B; Zhang L
Int J Cardiol; 2009 Jan; 131(2):225-33. PubMed ID: 18180059
[TBL] [Abstract][Full Text] [Related]
18. [Detection of differentially expressed proteins in the semen of oligospermia patients by SELDI-TOF-MS technology].
Liu CB; Liang Y; Pan CQ; Zhang J
Zhonghua Nan Ke Xue; 2009 Mar; 15(3):232-6. PubMed ID: 19452695
[TBL] [Abstract][Full Text] [Related]
19. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides.
Penno MA; Ernst M; Hoffmann P
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2656-62. PubMed ID: 19630030
[TBL] [Abstract][Full Text] [Related]
20. Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.
Simonsen AH; Bahl JM; Danborg PB; Lindstrom V; Larsen SO; Grubb A; Heegaard NH; Waldemar G
J Neurosci Methods; 2013 May; 215(2):234-40. PubMed ID: 23537933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
